Baxter International stock heads into the open after a recent gain

At the close on September 11, 2026, Baxter International stock was quoted at USD 23.80, reflecting a positive year-to-date performance. The shares traded within a narrow intraday range and outpaced the broader market on that date.

Baxter International stock closed at USD 23.80 on the New York Stock Exchange on September 11, 2026, marking a positive move versus its prior levels. The share price advanced modestly in percent terms and extended a solid year-to-date gain that has drawn investor attention. On that date the stock outperformed a major US equity benchmark, underscoring relative strength in recent trading.

September 11, 2026 in numbers

Baxter International Inc. (ISIN US0673431090) finished the session on September 11, 2026 at USD 23.80, with the closing price sitting within the day’s intraday high and low on its primary US venue. The daily percent change versus the previous trading day’s close was positive, and the move contributed to a year-to-date gain of 24.5 percent as of September 11, 2026, according to Ad-hoc-news. On that date Baxter International’s performance compared favorably with the broader US stock market, as the company’s year-to-date return exceeded that of a key reference index cited in the same report. Trading volume on September 11, 2026 was consistent with recent averages, and the closing price remained within the stock’s published 52-week range, indicating that the shares were neither at their highest nor lowest level of the past year.

Today’s focus for Baxter International

Today, September 16, 2026, Baxter International heads into the open without a confirmed company-specific event such as an earnings release or shareholder meeting scheduled for this session in the available calendars. Broader market factors, including recent moves in US bond yields and energy prices that have affected overall equity sentiment in mid-September, may continue to influence trading conditions for healthcare and medical-technology names like Baxter International, as discussed by outlets such as Pittsburgh Post-Gazette. Investors also remain attentive to upcoming central-bank decisions and US economic data releases in the days ahead, which can affect valuations across the defensive and growth segments of the market.